Aethlon Medical, Inc.
AEMD
$1.39
$0.0251.83%
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | 574.20K | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | 574.20K | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | 574.20K | -- |
SG&A Expenses | 2.69M | 3.18M | 3.41M | 3.05M | 2.85M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 2.69M | 3.18M | 3.41M | 3.05M | 2.85M |
Operating Income | -2.69M | -3.18M | -3.41M | -2.48M | -2.85M |
Income Before Tax | -3.47M | -3.03M | -3.28M | -2.47M | -2.85M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -3.47M | -3.03M | -3.28M | -2.47M | -2.85M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -3.47M | -3.03M | -3.28M | -2.47M | -2.85M |
EBIT | -2.69M | -3.18M | -3.41M | -2.48M | -2.85M |
EBITDA | -2.60M | -3.08M | -3.32M | -2.40M | -2.77M |
EPS Basic | -1.38 | -1.22 | -1.35 | -1.08 | -1.24 |
Normalized Basic EPS | -0.64 | -0.76 | -0.84 | -0.67 | -0.78 |
EPS Diluted | -1.38 | -1.22 | -1.40 | -1.11 | -1.24 |
Normalized Diluted EPS | -0.64 | -0.76 | -0.84 | -0.67 | -0.78 |
Average Basic Shares Outstanding | 2.52M | 2.48M | 2.43M | 2.29M | 2.29M |
Average Diluted Shares Outstanding | 2.52M | 2.48M | 2.43M | 2.29M | 2.29M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |